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1. Introduction 
Patients with acute kidney failure (AKF) and chronic kidney failure (CKF) require an 
appropriate vascular access for hemodialysis [1]. Vascular access is needed to allow blood 
flow through an extracorporeal circulation system with a blood pump connected to a 
hemodialysis monitor driving the blood through a dialysis filter (dialysator). Satisfactory 
levels of blood flow range between 300 and 400 mL/min.  
The need for vascular access in patients with kidney failure may be temporary or permanent 
[2]. 
2. Temporary hemodialysis vascular access  
Temporary hemodialysis access is required in patients scheduled to start hemodialysis 
treatment in several days to six months. It is mostly needed in patients with AKF of various 
etiology [3]. For that purpose, a hemodialysis catheter is introduced percutaneously into one 
of the large central veins (the internal jugular, subclavian or femoral veins) under local 
anesthesia. Catheters are made of different materials (polyurethane, silicon, and so on). 
Single-lumen catheters are used less often than double-lumen catheters of different lengths 
(usually 15 to 24 cm, rarely of other lengths – shorter are for pediatric use, and longer for 
permanent use) and 11.5-14 F in diameter. They are available in two configurations - straight 
and curved. A catheter is introduced after the puncture of an appropriate vein performed 
either in a “blinded” fashion or under ultrasound control [4]. Before the venipuncture, 
ultrasound should be used to visualize the relative anatomic position of the internal jugular 
vein and common carotid artery and determine the possible direction of puncture angle and 
depth in order to avoid the unwanted puncture of the common carotid artery (Figure 1).  
After the catheter placement, a control chest x-ray is recommended to confirm the correct 
position of the catheter and exclude possible complications (Figure 2).  
 
Aneurysm 454 
 
 
 
Source: Archive of the Department of Nephrology and Dialysis, University Hospital Rijeka 
Figure 1. Ultrasonographic assesment in the B-mode of the internal jugular vein (V.J.I) and common 
carotid artery (A.C.C.). 
Temporary vascular access for hemodialysis is sometimes indicated in patients with CKF 
stage 5, or end-stage kidney disease (ESKD), who are on regular dialysis, in cases of 
inadequate function of arteriovenous fistula (AV) or AV graft due to stenosis or thrombosis, 
and in new hemodialysis patients in whom AV fistula has not been created in a timely 
manner [5]. 
3. Permanent hemodialysis vascular access 
Permanent vascular access is usually required in patients with CKF stage 4 because of 
permanent HD treatment [6]. For permanent vascular access, AV shunt (out of clinical use), 
AV fistula, AF graft or tunneled or non-tunneled hemodialysis catheters may be used. 
During the pre-dialysis preparation or pre-dialysis education program, the patients should 
be informed about possible ESKG treatment options, which include HD, peritoneal dialysis 
(PD), and kidney transplantation. 
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Source: Archive of the Department of Nephrology and Dialysis, University Hospital Rijeka 
Figure 2. Chest radiogram showing correct position of the jugular cateter in the right atrium. 
3.1. Arteriovenous shunt 
External AV shunt belongs to history. It was used between 1960 and 1965, before the first 
AV fistula was created (Kenneth C. Apple), that is, radiocephalic (Brescia–Cimino 1966) 
(Figure 3). 
3.2. Arteriovenous fistula  
In patients on chronic hemodialysis, vascular access should be created in a timely fashion. 
Native AV fistula is the gold standard and the most frequently used type of vascular access in 
these patients [2]. After examining the patient in CKF stage 4 (GFR 30-15 mL/min/1.73 m²), a  
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Source: Archive of the Department of Nephrology and Dialysis, University Hospital Rijeka 
Figure 3. Quinton-Scribner AV sunt 
vascular surgeon makes an assessment of the patient’s vascular system in order to plan for 
the AV fistula construction. In case of progressive kidney failure and/or diabetes mellitus, 
AV fistula should be created earlier [7]. Before choosing the type of vascular access, 
peripheral blood vessels (arteries and veins) should be evaluated by clinical examination 
and ultrasound. If diameters and walls of the blood vessels are satisfactory, AV fistula may 
be created. It is usually done on the non-dominant arm between the radial artery and 
cephalic vein as distally as possible. AV fistula is a surgically created subcutaneous 
anastomosis between an artery and a vein (Figure 4) and it matures by venous dilatation 
and arterialisation of the vein.  
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Figure 4. Typical arterivenous fistula (Brescia-Cimino)     
The AV anastomosis redirects arterial blood flow into the vein, which then becomes dilated 
due to new hemodynamic conditions. Over time, the lumen of the vein widens, the venous 
blood flow increases, and the vein becomes suitable for puncture and hemodialysis usually 
after three to five weeks [8]. 
There two most common types of anastomosis. One is “side-to-side” (a standard 
anastomosis described by Brescia), where an artery and its neighboring vein are cut 
longitudinally and sewn or stapled together [9]. This type of anastomosis may lead to the 
venous hyperemia of the arm (Figure 5).  
The other is “end-vein to side-artery” anastomosis, where the cephalic vein is completely 
severed, its distal part toward the hand is ligated, and the proximal part is sewn to the side 
of the relevant artery (Figure 6). 
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Figure 5. “Side to side“ anastomosis of the AV fistula 
 
Figure 6. “End to side“ anastomosis of the AV fistula 
If AV fistula cannot be created at the usual site, i.e., the wrist, it may be created proximally 
in the middle part of the forearm or cubital fossa. The fistula may also be created between 
the ulnar artery and the basilic vein. 
3.3. AV fistula complications 
3.3.1. Thrombosis 
AV fistula thrombosis is characterized by a complete cessation of blood flow through the 
venous part of the AF fistula proximal to the AV anastomosis due to a thrombus, which may 
develop in any part of the vein (from the anastomosis to the confluence of the subclavian 
vein into the superior vena cava). Thrombosis may be diagnosed by a standard physical 
examination. The characteristic sign is the absence of the typical thrill of the fistula on 
palpation. In some cases, the thrombus in the vein may be palpable. Arterial pulsations may 
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be noticed distal and the absence of blood flow in the empty vein proximal to the site of 
thrombosis. No AV fistula bruit can be heard with a stethoscope. The findings may be 
confirmed by ultrasound, i.e. the thrombus may be visualized and measured by B mode 
ultrasound, and the absence of the circulation proximal to the thrombosis site may be 
confirmed by Doppler [10]. 
Thrombosis is the most serious complication leading to the loss of function of the fistula. It is 
treated surgically by thrombectomy or via endovascular route.  
3.3.2. Stenosis 
Stenosis is the most frequent complication. It is caused by the luminal narrowing of the vein. 
Although it may develop in any part of the vein, it is usually found close to the AV 
anastomosis. 
Stenosis leads to AV fistula malfunction characterized by a reduced blood flow through the 
arterial segment of the fistula in 50% of the cases. Reduced and inadequate blood flow 
through the AV fistula is registered by the blood pump, which results in inadequate dialysis  
doses [11]. Stenosis may be suspected if blood flow through a particular segment of the vein  
 
Source: Archive of the Department of Nephrology and Dialysis, University Hospital Rijeka 
Figure 7. Stenosos of the AV fistula as shown using ultrasonography in the B-mode with Doppler 
visualisation of the missing blood flow on the stenosis site. 
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is reduced. Frequently, a high-pitched bruit can be heard on auscultation. The diagnosis 
may be confirmed by ultrasound and phlebography. Priority should be given to B mode 
ultrasound and Doppler sonography, because these are non-invasive techniques that can 
precisely determine the location and degree of stenosis (Figure 7). 
These methods may be used to determine the length of stenosis and measure the diameter of the 
vein distal and proximal to the stenotic site. In addition, Doppler can detect higher blood flow 
velocity at the stenotic site [12]. Depending on the findings, a new anastomosis may be created 
proximal to the stenosis or a stent may be placed at the site of stenosis by a percutaneous 
intervention. If stenosis develops in the large veins of the neck (usually the subclavian vein), it 
leads to the edema of the entire arm and pronounced collateral venous blood flow through the 
subcutaneous veins. HD is complicated by high percentage of blood recirculation, difficult 
puncture of the vessel, and high venous resistance. The diagnosis of subclavian stenosis is made 
on the basis of physical and phlebographic findings; ultrasound may not produce reliable 
results. This complication is managed by percutaneous dilatation and stenting [13]. 
3.3.3. Aneurysm 
Aneurysm is defined as a localized dilation of the vein, usually proximal to the site of 
stenosis where the pressure on the vessel wall is increased due to blood turbulence and 
results in the aneurysmal widening of the vein [14]. Turbulent blood flow in aneurysmal 
dilatation often leads to AV fistula thrombosis. Aneurysms are diagnosed by inspection, 
palpation, and ultrasound (Figure 8).  
 
Source: Archive of the Department of Nephrology and Dialysis, University Hospital Rijeka 
Figure 8. Aneurismatic enlargment of the AV fistula. 
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3.3.4. Pseudoaneurysm 
As opposed to aneurysm, pseudoaneurysm does not contain vessel wall. It expands into the 
surrounding soft tissue after the destruction of the vessel wall, usually after a careless 
puncture of the artery or graft. Pseudoaneurysms more often develop as complications of 
synthetic AV grafts than native fistulas and are diagnosed by ultrasound. 
3.3.5. Hematoma 
Hematoma most often develops between the venipuncture site and the skin due to 
inadequate and short compression of the venipuncture site after a dialysis session. It may 
cause external compression of a segment of a blood vessel and create stenosis. Hematoma is 
diagnosed by inspection and ultrasound examination (Figure 9).  
 
Source: Archive of the Department of Nephrology and Dialysis, University Hospital Rijeka 
Figure 9. Hematom on the puncture sites of the AV fistula. 
3.3.6. Peripheral ischemia  
Since blood flow from the radial artery to the palmar arch and fingers is decreased after the 
creation of an AV fistula, vascular access “steal syndrome” may develop, resulting in 
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ischemia of the fingers. The thumb, index finger, and middle finger, which are supplied by 
the radial artery, are most often affected. The syndrome develops mostly in patients with 
diabetes mellitus and changes on the peripheral arteries (intimal hyperplasia, fibrosis, 
calcifying plaques, stenoses) due to diabetic angiopathy and reduced peripheral arterial 
circulation. Therefore, antecubital AV fistulae should be avoided in patients with diabetes 
mellitus [15]. Patients often complain of cold fingers and pain and they may develop trophic 
changes on the acral parts, including gangrene (Figure 10). 
 
Source: Archive of the Department of Nephrology and Dialysis, University Hospital Rijeka 
Figure 10. Pereipheral ishemia caused by “steal syndrome“ as a consequence of the insufficient blood 
flow in the distal part of the arm after AV fistula anastomosis. 
3.3.7. Cardiac complications 
Cardiac patients may develop additional cardiac complications after the creation of AF fistula, 
because cardiac output is increased (20–50% of the cardiac volume flows through an AV fistula) 
[16]. The blood flow through the AV fistula, depending on its location, is 600 - 2000 mL/min.  
3.3.8. Infection 
Infections most often occur after a non-sterile puncture of AV fistula and are characterized by 
redness and edema of the skin over the fistula. Due to the inflammatory changes, the blood 
vessel was may be weakened and rupture, especially if the changes affect the aneurysm. 
These complications are treated medically with antibiotics or surgically in case of imminent 
rupture (Figure 11) [17]. 
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Source: Archive of the Department of Nephrology and Dialysis, University Hospital Rijeka 
Figure 11. Infection of the AV fistula. Serotic extravasation is present on the puncture site. Crusta 
formations are sign of the active inflammatory process. 
3.4. Arteriovenous graft 
If native AV fistula cannot be created due to inadequate blood vessels (poorly developed 
veins or arterial insufficiency), a synthetic blood vessel may be implanted between the 
artery and the vein. Such an implanted vessel is called AV graft. A graft is made of 
biocompatible material, such as polyesther (Dacron), expanded polytetrafluoroethylene 
(Goretex) or polyurethane (Vectra), in order to avoid allergic reactions, thrombosis, and 
infection. It is implanted subcutaneously to be available for puncture, mostly on the upper 
arm between the brachial artery and axillary vein and less often on the forearm or thigh 
(Figure 12) [20]. 
3.4.1. Complications 
AV graft complications are similar to those described for native AV fistulas and include 
thrombosis, stenosis, pseudoaneurysm, and infections and are managed in a similar way. 
 
Aneurysm 464 
 
Figure 12. Schematic view of the arteriovenous graft 
3.5. Tunneled central venous catheters 
In some elderly patients with chronic heart failure syndrome and inadequate peripheral 
blood vessels, it is not possible to create an AV fistula or implant a synthetic AV graft. 
Therefore, a permanent tunneled central venous catheter (CVC) with a subcutaneous 
synthetic cuff is often implanted in these patients [19]. Connective tissue grows into the cuff 
and anchors the catheter in place, at the same time reducing the possibility of infection 
(Figure 13).  
This approach is used in the treatment of 10–15% patients in the chronic HD program. The 
patients should be informed about the tunneled CVC-associated complications, which are 
more frequent than those associated with AV fistulas or AV grafts (thrombosis, bacteremia, 
sepsis). Double-lumen catheters are introduced through large veins (the internal jugular, 
subclavian or femoral veins) and connected via tubing with the blood pump, which ensures 
a sufficient blood flow (300 to 400 mL/min) and is controlled via an HD monitor. The most 
desirable site for tunneled CVC placement is the right internal jugular vein. Alternative sites 
include the external jugular vein, subclavian vein, femoral vein, and inferior vena cava. If 
the vascular access is temporary, it should not be placed on the same side of the body where  
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Source: Archive of the Department of Nephrology and Dialysis, University Hospital Rijeka 
Figure 13. Tunneled catheter for hemodialysis, Tesio model. Two separate lumen are suitable for better 
blood flow and less recirculation. 
the creation of fistula is planned. The subclavian vein should be used only if jugular access is 
not possible. The catheter is inserted using the modified Seldinger technique under ultrasound 
control. The jugular access is located superior and lateral to the sternal end of the clavicle. 
After a successful placement, the position of tunneled CVC should be confirmed by x-ray. 
There are several advantages of tunneled CVC. It may be used immediately after placement, it 
does not require venipuncture (lower risk of heparin-associated bleeding), and possible 
thrombotic complications at the access site are easier to manage. Disadvantages of a tunneled 
CVC include lower blood flow through the dialyzer, possible complications during catheter 
placement, higher risk of infection, stenosis of the subclavian vein, and cosmetic problems [2]. 
3.5.1. Complications 
Complications related to tunneled hemodialysis catheters may be early and late. Early 
complications are usually mild, such as hematoma at the puncture site, puncture of the 
common carotid artery, inadequate catheter position (most often due to stenosis of the 
bachiocephalic vein), hoarseness, and paresthesia of the limb on the puncture side due to 
anesthetic infiltration to the innervating area of the recurrent nerve and brachiocephalic 
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nerve plexus. More severe complications include pneumothorax, hemothorax, and 
hemopericardium with an imminent cardiac tamponade. Late complications include 
thrombosis, infection (usually in the subcutaneous tunnel) resulting in bacteremia and, in 
severe cases, sepsa (Figure 14) [20].  
 
Source: Archive of the Department of Nephrology and Dialysis, University Hospital Rijeka 
Figure 14. Infection of the exit-site of the catheter lumen. Complete protrusion of the cuff. 
3.5.2. Thrombosis 
Thrombosis leads to inadequate blood flow through the catheter. It is a relatively frequent 
complication in dialysis patients with intravenous catheters. Reduced blood flow reduces the 
delivered dialysis dose. Tunneled catheters normally have a blood flow rate of >300 mL/min. 
If the blood flow rate is lower, incomplete obstruction caused by endoluminal fibrin deposits 
may be suspected. In case of complete obstruction, dialysis is not possible; therefore, the non-
functional catheter should be replaced by a new one via new subcutaneous tunnel [21]. 
Fibrinolytic agents (urokinase, tissue plasminogen activator – tPA) may be administered 
over 3-6 hours. In case of incomplete obstruction, instillation of antithrombotic solutions 
(standard heparin, low-molecular-weight heparin, sodium citrate) into the lumen of the 
catheter is recommended [22, 23]. 
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Sodium nitrate has recently been used more often than standard heparin for the prevention 
of hemodialysis catheter infection and thrombosis. As a polysaccharide, heparin attracts 
microbes and contributes to the development of biofilm on catheter surfaces. If it enters the 
systemic circulation, it increases the risk of bleeding. Sodium citrate prevents possible 
infection by “binding” calcium needed for bacterial growth and prevents the formation of 
thrombus by blocking calcium. If it enters the systemic circulation, it has no systemic effect 
because it is rapidly metabolized in the liver and muscle tissue to neutral bicarbonates. The 
observed adverse reactions (occurring in approximately 10% of the patients) are transitory 
and include metallic taste and numbness in the fingers and toes while the lumen of the 
catheter is being filled with the solution. These reactions may be avoided it the volume of 
the administered solution is tapered in 0.1 ml decrements in each subsequent dialysis 
session until the symptoms resolve. The concentrations of sodium citrate that are in use 
include 23%, 30% i 46.7% solutions [24, 25]. 
3.5.3. Infection 
Catheter-associated infections are the most frequent cause of illness in patients with this 
type of vascular access. Diagnosis is not difficult to make. It is based on increased body 
temperature and pain and redness around the catheter exit site or subcutaneous tunnel often 
accompanied by discharge. The diagnosis of silent endoluminal contamination is more 
difficult to make, especially if the external signs of inflammation are absent. It that case, 
positive hemoculture or positive bacterial culture from intraluminal thrombus helps the 
diagnosis. 
The most common causative agents (80%) include Gram-positive bacteria (Staphylococcus 
epidermidis, Staphyloccus aureus), whereas Gram-negative bacteria and fungi (Enterococcus, 
Escherichia coli, Pseudomonas, Candida species) are less common (20%). Specific blood 
markers (leukocytosis, increased C-reactive protein, increased procalcitonin) may help in the 
diagnosis of catheter-associated bacterial infection [26]. 
Management of known catheter-associated infection 
a. In case of the catheter exit site or tunnel infection with negative hemoculture, toilet of 
the exit or tunnel should be performed. Exit swabs should be taken for microbiological 
analysis and a two-week antibiogram-based antibiotic therapy should be administered. 
Since Gram-positive bacteria are the causative agents in 80% of the cases, treatment 
with antibiotics to which Gram-positive bacteria are susceptible may be introduced 
immediately and maintained until the microbiological results become available. 
b.  In case of positive hemoculture without any clinical signs of the catheter exit site or 
tunnel infection, it is advisable to replace the catheter and introduce antibiotic 
prophylaxis based on the microbial susceptibility test results over the next 4 weeks. 
c. In case of the catheter exit site or tunnel infection and positive hemoculture, the catheter 
should be immediately removed and antimicrobial treatment should be administered 
over the next 4 weeks to decrease the risk of catheter-associated sepsis and possible 
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development of metastatic infection, such as endocarditis, osteomyelitis, and vertebral 
abscess, which may sometimes develop even after the catheter has been removed 
3.5.4. Infection prevention 
Strict hygienic measures during dialysis sessions, the use of sodium citrate solution for the 
maintenance of the catheter patency between dialysis sessions due to its antithrombotic and 
antiseptic characteristics, and preventive application of protective antimicrobial ointment on 
the skin around the catheter exit site will reduce the risk of bacteremia [28]. 
4. Conclusion 
Adequate patient preparation for hemodialysis includes AV fistula construction in time. AV 
fistula is the most appropriate type of vascular access for hemodialysis with less 
complication in comparison to other vascular access types. Use of endovenous catheters is 
sometimes needed, but should be limited only for emergency or in the patients with 
exhausted vessels for AV fistula or AV graft construction. 
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